Heron Therapeutics

Updates from The Motley Fool

Latest updates on Heron Therapeutics from Fool.com.
7 Stocks to Buy in January

After the broader market's painful pullback so early this year, skittish investors might be tempt...

Avoid This Pharma Stock

Editor's note: This article is a stock pitch made by a member on CAPS, The Motley Fool's free inv...

Stock Performance

View Interactive HRTX Charts
Sponsored by

Key Data Points

Primary metrics and data points about Heron Therapeutics.
Current Price: $15.75
Prev Close: $15.90
Open: $16.20
Bid: $15.65
Ask: $16.80
Day's Range: $15.60 - $16.48
52wk Range: $14.75 - $31.32
Volume: 317,682
Avg Vol 593,105
Market Cap: $567M
P/E (ttm): 6.88
EPS (ttm): $2.31
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Heron Therapeutics.
CAPS Rating 2 out of 5
19 Outperform
12 Underperform
CAPS All Stars
5 Outperform
6 Underperform

How do you think Heron Therapeutics will perform against the market?

You pick for Heron Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

Business Summary

Industry, sector and description for Heron Therapeutics.

Heron Therapeutics

  • Exchange: NASDAQ
  • Sector: Healthcare
  • Industry: Drug Makers